Applicant, as named in the Orange Book

Endo Operations

Next listed expiry: Aveed on 8 May 2027. 1 products with live protection, 4 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Aveed NDA 022219 testosterone undecanoate	testosterone undecanoate	8 May 2027 patent, carve-out possible	patent, carve-out possible

Recent events

Sumavel Dosepro · Enters 12-month window basis: patentListed date 22 Nov 2026Detected 24 Oct 2026
Aveed · Enters 12-month window basis: patent, carve-out possibleListed date 8 May 2027Detected 24 Oct 2026

Products without listed protection (4)

Drug	Ingredient	Earliest generic entry	Basis
Edex NDA 020649 · 6 strengths alprostadil	alprostadil	open now no listed protection	no listed protection
Supprelin La NDA 022058 histrelin acetate	histrelin acetate	open now no listed protection	no listed protection
Testim NDA 021454 testosterone	testosterone	open now no listed protection	no listed protection
Valstar Preservative Free NDA 020892 valrubicin	valrubicin	open now no listed protection	no listed protection